ストックスクリーナーアプリを入手
306.05
2.72%
8.09
アフターアワーズ：
306.05
前日終値:
$297.96
開ける：
$310.72
24時間の取引高:
360.22K
Relative Volume:
0.99
時価総額：
$33.54B
収益：
$3.81B
当期純損益:
$-644.79M
株価収益率:
-49.05
EPS:
-6.24
ネットキャッシュフロー:
$-669.77M
1週間 パフォーマンス:
-2.43%
1か月 パフォーマンス:
+0.10%
6か月 パフォーマンス:
+12.60%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$306.05
$314.90
1週間の範囲:
$295.22
$320.00
52週間の値動き範囲:
$172.67
$330.63
Beone Medicines Ltd Adr Stock (ONC) Company Profile
名前
Beone Medicines Ltd Adr
セクター
電話
41-616851900
住所
C/O BEONE MEDICINES I GMBH, BASEL
ONC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.68B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.33B | 3.06B | 1.28B | 447.35M | 21.30 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-03-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-12-03 | 再開されました | Morgan Stanley | Overweight |
| 2024-09-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-02-06 | 再開されました | JP Morgan | Overweight |
| 2023-09-12 | 開始されました | Macquarie | Outperform |
| 2023-08-17 | 開始されました | Jefferies | Buy |
| 2023-07-17 | 開始されました | Citigroup | Buy |
| 2023-06-30 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 開始されました | Daiwa Securities | Buy |
| 2022-10-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-10-13 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 再開されました | JP Morgan | Overweight |
| 2022-03-17 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 開始されました | Deutsche Bank | Buy |
| 2021-10-12 | 開始されました | Bernstein | Outperform |
| 2021-10-06 | アップグレード | CLSA | Underperform → Buy |
| 2021-03-08 | 開始されました | China Renaissance | Buy |
| 2021-03-01 | ダウングレード | CLSA | Outperform → Underperform |
| 2020-11-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-11-06 | ダウングレード | Piper Sandler | Neutral → Underweight |
すべてを表示
Beone Medicines Ltd Adr (ONC) 最新ニュース
BeOne Medicines Stock Gains Momentum With Early-Stage Trial Success For Pretreated Lymphoma Patients - Benzinga
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives Average Rating of "Buy" from Analysts - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Rating of “Buy” from Analysts - Defense World
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Average Recommendation of “Buy” from Analysts - Defense World
Insider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 11,013 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 39,936 Shares - MarketBeat
Xiaobin Wu Sells 49,858 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) Sets New 52-Week HighShould You Buy? - MarketBeat
BeOne Medicines (NASDAQ:ONC) Hits New 1-Year High – What’s Next? - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat
BeOne Medicines (NASDAQ:ONC) Sets New 12-Month HighWhat's Next? - MarketBeat
BeOne Medicines DRC earnings missed by $0.04, revenue topped estimates - Investing.com India
Analysts Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) PT at $327.56 - Defense World
Chan Henry Lee Sells 920 Shares of BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Stock - MarketBeat
Insider Selling: BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Insider Sells 259 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) Reaches New 12-Month HighHere's What Happened - MarketBeat
BeOne Medicines stock hits 52-week high at 304.0 USD - Investing.com India
Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End - Ariva
BeOne Medicines stock rises after positive EU opinion for lung cancer drug - Investing.com India
Lai Wang Sells 700 Shares of BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Stock - MarketBeat
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo Finance
BeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High After Analyst Upgrade - MarketBeat
BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week High Following Analyst Upgrade - Defense World
BeOne Medicines (NASDAQ:ONC) Shares Gap UpTime to Buy? - MarketBeat
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in Stock - Defense World
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World
AFC Gamma (NASDAQ:AFCG) Shares Down 4.9% – What’s Next? - Defense World
Beone Medicines Ltd Adr (ONC) 財務データ
収益
当期純利益
現金流量
EPS
Beone Medicines Ltd Adr (ONC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wu Xiaobin | President and COO |
Aug 14 '25 |
Option Exercise |
156.45 |
39,936 |
6,247,989 |
39,936 |
| Wu Xiaobin | President and COO |
Aug 13 '25 |
Sale |
304.16 |
49,858 |
15,164,818 |
0 |
| Wu Xiaobin | President and COO |
Aug 14 '25 |
Sale |
305.06 |
39,936 |
12,182,818 |
0 |
| Lee Chan Henry | SVP, General Counsel |
Aug 13 '25 |
Option Exercise |
177.90 |
8,230 |
1,464,080 |
8,230 |
| Lee Chan Henry | SVP, General Counsel |
Aug 13 '25 |
Sale |
300.45 |
11,013 |
3,308,877 |
0 |
0.84%
1.89%
大文字化:
|
ボリューム (24 時間):